There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 errors: PMID
Jump to navigation
Jump to search
Pages in category "CS1 errors: PMID"
The following 200 pages are in this category, out of 1,527 total.
(previous page) (next page)C
- Chorioamnionitis laboratory findings
- Chorioamnionitis medical therapy
- Chorioamnionitis MRI
- Chorioamnionitis pathophysiology
- Chronic diarrhea causes
- Chronic diarrhea history and symptoms
- Chronic diarrhea laboratory findings
- Chronic diarrhea medical therapy
- Chronic diarrhea risk factors
- Chronic hypertension blood pressure measurement
- Chronic hypertension differential diagnosis
- Chronic hypertension medical therapy
- Chronic hypertension medical therapy blood pressure goals of treatment
- Chronic hypertension natural history
- Chronic hypertension pathophysiology
- Chronic myelogenous leukemia differential diagnosis
- Chronic neutrophilic leukemia differential diagnosis
- Chronic obstructive pulmonary disease medical therapy
- Chronic pain medical therapy
- Chronic pelvic pain
- Chronic pelvic pain resident survival guide
- Chronic renal failure causes
- Chronic renal failure historical perspective
- Chronic renal failure medical therapy
- Chronic renal failure pathophysiology
- Chronic stable angina revascularization percutaneous coronary intervention
- Chronic total occlusions
- Ciprofloxacin (oral)
- Circadian control element gene transcriptions
- Clinic
- Cohort study
- Collateral circulation
- Colorectal cancer screening
- Commotio cordis echocardiography or ultrasound
- Commotio cordis electrocardiogram
- Commotio cordis other diagnostic studies
- Commotio cordis other imaging findings
- Commotio cordis primary prevention
- Commotio cordis risk factors
- Community-acquired pneumonia classification
- Community-acquired pneumonia medical therapy
- Community-acquired pneumonia physical examination
- Comorbidity
- Complex locus A1BG and ZNF497
- Compliance (medicine)
- Complications Based Questions
- Congenital diaphragmatic hernia causes
- Congenital diaphragmatic hernia differential diagnosis
- Congenital diaphragmatic hernia epidemiology and demographics
- Congenital diaphragmatic hernia laboratory findings
- Congenital diaphragmatic hernia medical therapy
- Congenital diaphragmatic hernia natural history, complications and prognosis
- Congenital diaphragmatic hernia pathophysiology
- Congenital diaphragmatic hernia physical examination
- Congenital diaphragmatic hernia risk factors
- Congenital diaphragmatic hernia screening
- Congenital diaphragmatic hernia secondary prevention
- Congenital diaphragmatic hernia surgery
- Congenital Toxoplasmosis
- Congestive heart failure ACE inhibitors
- Congestive heart failure acute pharmacotherapy
- Congestive heart failure AHA recommendations Coordinating Care for Patients With Chronic HF
- Congestive heart failure AHA recommendations for hospitalized patient
- Congestive heart failure AHA recommendations for patients with a prior MI
- Congestive heart failure AHA recommendations Quality Metrics/Performance Measures
- Congestive heart failure aldosterone antagonists
- Congestive heart failure and obstructive sleep apnea
- Congestive heart failure angiotensin receptor blockers
- Congestive heart failure angiotensin receptor-neprilysin inhibitor
- Congestive heart failure antiarrhythmic drugs
- Congestive heart failure beta blockers
- Congestive heart failure calcium channel blockers
- Congestive heart failure cardiac catheterization
- Congestive heart failure cardiac MRI
- Congestive heart failure chest x ray
- Congestive heart failure chronic pharmacotherapy
- Congestive heart failure classification
- Congestive heart failure clinical assessment
- Congestive heart failure diuretics
- Congestive heart failure drugs to avoid
- Congestive heart failure echocardiography
- Congestive heart failure electrocardiogram
- Congestive heart failure end-of-life considerations
- Congestive heart failure epidemiology and demographics
- Congestive heart failure exercise stress testing
- Congestive heart failure history and symptoms
- Congestive heart failure implantation of intracardiac defibrillator
- Congestive heart failure iron
- Congestive heart failure laboratory tests
- Congestive heart failure left ventricular assist devices
- Congestive heart failure Management of Acute heart failure
- Congestive heart failure myocardial viability study
- Congestive heart failure natural history
- Congestive heart failure other pharmacotherapies
- Congestive heart failure pharmacotherapy
- Congestive heart failure physical examination
- Congestive heart failure positive inotropics
- Congestive heart failure risk factors
- Congestive heart failure Sodium-glucose co-transporter 2 inhibitors
- Congestive heart failure treatment of associated conditions
- Congestive heart failure Treatment of Heart failure with preserved ejection fraction
- Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
- Congestive heart failure treatment of patients who have concomitant disorders
- Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
- Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
- Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)
- Congestive heart failure treatment of special populations
- Congestive heart failure treatment of underlying causes
- Congestive heart failure vasodilators
- Congestive heart failure with preserved EF pharmacotherapy
- Conjunctivitis in children
- Conjunctivitis resident survival guide
- Constipation resident survival guide (pediatrics)
- Contrast induced nephropathy definition
- Contrast induced nephropathy primary prevention
- Contrast induced nephropathy risk factors
- Coronary artery bifurcation
- Coronary artery bypass surgery anesthetic considerations
- Coronary artery bypass surgery cardiopulmonary bypass
- Coronary artery bypass surgery central nervous system monitoring
- Coronary artery bypass surgery conduits used for bypass
- Coronary artery bypass surgery epiaortic ultrasound
- Coronary artery bypass surgery in association with other cardiac procedures
- Coronary artery bypass surgery indications
- Coronary artery bypass surgery maintaining glucose level
- Coronary artery bypass surgery perioperative management
- Coronary artery bypass surgery post-operative care and complications
- Coronary artery bypass surgery prognosis
- Coronary artery bypass surgery pulmonary artery catheterization
- Coronary artery bypass surgery TEE
- Coronary artery bypass surgery the traditional coronary artery bypass grafting procedure (simplified)
- Coronary artery calcification
- Coronary heart disease CT
- Coronary heart disease history and symptoms
- Coronary heart disease natural history, complications and prognosis
- Coronary heart disease other diagnostic studies
- Coronary heart disease primary prevention
- Coronary heart disease surgery
- Coronary revascularization
- Coronavirus epidemiology and demographics
- Cough chest x ray
- Cough classification
- Cough CT
- Cough echocardiography or ultrasound
- Cough epidemiology and demographics
- Cough history and symptoms
- Cough in children
- Cough laboratory findings
- Cough medical therapy
- Cough natural history, complications and prognosis
- Cough other diagnostic studies
- Cough other imaging findings
- Cough pathophysiology
- Cough physical examination
- Cough resident survival guide
- Cough risk factors
- Cough surgery
- COVID-19
- COVID-19 and influenza co-infection
- COVID-19 associated abdominal pain differential diagnosis
- COVID-19 associated anorexia differential diagnosis
- COVID-19 associated diarrhea differential diagnosis
- COVID-19 associated pediatric complications
- COVID-19 Cardiovascular Complications
- COVID-19 causes
- COVID-19 CT scan
- COVID-19 Der Gastrointestinal atologic Complications
- COVID-19 Dermatologic Complications
- COVID-19 diagnostic study of choice
- COVID-19 differential diagnosis
- COVID-19 echocardiography and ultrasound
- COVID-19 epidemiology and demographics
- COVID-19 frequently asked outpatient questions
- COVID-19 future or investigational therapies
- COVID-19 Hematologic Complications
- COVID-19 history and symptoms
- COVID-19 in Diabetics
- COVID-19 Infection in Transplant Patients
- COVID-19 interventions
- COVID-19 laboratory findings
- COVID-19 medical therapy
- COVID-19 natural history, complications and prognosis
- COVID-19 Nephrologic Complications
- COVID-19 non-medical therapy
- COVID-19 other diagnostic studies
- COVID-19 pathophysiology
- COVID-19 physical examination
- COVID-19 primary prevention
- COVID-19 screening
- COVID-19 secondary prevention
- COVID-19 vaccines
- COVID-19 Variants of Concern
- COVID-19-associated abdominal pain
- COVID-19-associated acute kidney injury
- COVID-19-associated acute kidney injury causes
- COVID-19-associated acute respiratory distress syndrome
- COVID-19-associated alopecia
- COVID-19-associated anemia
- COVID-19-associated anorexia
- COVID-19-associated anosmia
Media in category "CS1 errors: PMID"
The following 2 files are in this category, out of 2 total.
-
Cochrane.2020.pmid.32584464.png 596 × 407; 19 KB
-
COVID-19 - Dx testing.png 475 × 333; 15 KB
